449 related articles for article (PubMed ID: 20682849)
1. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
2. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
[TBL] [Abstract][Full Text] [Related]
3. Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
Cazade M; Nuss CE; Bidaud I; Renger JJ; Uebele VN; Lory P; Chemin J
Mol Pharmacol; 2014 Feb; 85(2):218-25. PubMed ID: 24214826
[TBL] [Abstract][Full Text] [Related]
4. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
6. Biophysical and pharmacological characterization of spermatogenic T-type calcium current in mice lacking the CaV3.1 (alpha1G) calcium channel: CaV3.2 (alpha1H) is the main functional calcium channel in wild-type spermatogenic cells.
Stamboulian S; Kim D; Shin HS; Ronjat M; De Waard M; Arnoult C
J Cell Physiol; 2004 Jul; 200(1):116-24. PubMed ID: 15137064
[TBL] [Abstract][Full Text] [Related]
7. T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats.
Uslaner JM; Smith SM; Huszar SL; Pachmerhiwala R; Hinchliffe RM; Vardigan JD; Nguyen SJ; Surles NO; Yao L; Barrow JC; Uebele VN; Renger JJ; Clark J; Hutson PH
Neuropharmacology; 2012 Mar; 62(3):1413-21. PubMed ID: 21110986
[TBL] [Abstract][Full Text] [Related]
8. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
[TBL] [Abstract][Full Text] [Related]
9. Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Wang Q; Lu L; Gao X; Wang C; Wang J; Cheng J; Gao R; Xiao H
Pharmacology; 2011; 87(1-2):70-80. PubMed ID: 21228613
[TBL] [Abstract][Full Text] [Related]
10. T-type Ca2+ channels encode prior neuronal activity as modulated recovery rates.
Uebachs M; Schaub C; Perez-Reyes E; Beck H
J Physiol; 2006 Mar; 571(Pt 3):519-36. PubMed ID: 16423851
[TBL] [Abstract][Full Text] [Related]
11. Rebound excitation triggered by synaptic inhibition in cerebellar nuclear neurons is suppressed by selective T-type calcium channel block.
Boehme R; Uebele VN; Renger JJ; Pedroarena C
J Neurophysiol; 2011 Nov; 106(5):2653-61. PubMed ID: 21849607
[TBL] [Abstract][Full Text] [Related]
12. Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.
Cataldi M; Lariccia V; Marzaioli V; Cavaccini A; Curia G; Viggiano D; Canzoniero LM; di Renzo G; Avoli M; Annunziato L
J Neurophysiol; 2007 Oct; 98(4):2274-84. PubMed ID: 17699699
[TBL] [Abstract][Full Text] [Related]
13. CSTX-1, a toxin from the venom of the hunting spider Cupiennius salei, is a selective blocker of L-type calcium channels in mammalian neurons.
Kubista H; Mafra RA; Chong Y; Nicholson GM; Beirão PS; Cruz JS; Boehm S; Nentwig W; Kuhn-Nentwig L
Neuropharmacology; 2007 Jun; 52(8):1650-62. PubMed ID: 17517422
[TBL] [Abstract][Full Text] [Related]
14. Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels.
Berecki G; Motin L; Haythornthwaite A; Vink S; Bansal P; Drinkwater R; Wang CI; Moretta M; Lewis RJ; Alewood PF; Christie MJ; Adams DJ
Mol Pharmacol; 2010 Feb; 77(2):139-48. PubMed ID: 19892914
[TBL] [Abstract][Full Text] [Related]
15. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
[TBL] [Abstract][Full Text] [Related]
16. Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
Sakkaki S; Gangarossa G; Lerat B; Françon D; Forichon L; Chemin J; Valjent E; Lerner-Natoli M; Lory P
Neuropharmacology; 2016 Feb; 101():320-9. PubMed ID: 26456350
[TBL] [Abstract][Full Text] [Related]
17. Actions of U-92032, a T-type Ca2+ channel antagonist, support a functional linkage between I(T) and slow intrathalamic rhythms.
Porcello DM; Smith SD; Huguenard JR
J Neurophysiol; 2003 Jan; 89(1):177-85. PubMed ID: 12522170
[TBL] [Abstract][Full Text] [Related]
18. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
19. Voltage- and use-dependent inhibition of Na+ channels in rat sensory neurones by 4030W92, a new antihyperalgesic agent.
Trezise DJ; John VH; Xie XM
Br J Pharmacol; 1998 Jul; 124(5):953-63. PubMed ID: 9692781
[TBL] [Abstract][Full Text] [Related]
20. Modulation of native T-type calcium channels by omega-3 fatty acids.
Danthi SJ; Enyeart JA; Enyeart JJ
Biochem Biophys Res Commun; 2005 Feb; 327(2):485-93. PubMed ID: 15629140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
